Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 18,012 | 9,706 | 7,435 | 6,272 | 6,283 |
| Operating Income | -18,012 | -9,706 | -7,435 | -6,272 | -6,283 |
| Other Income | 406 | -128 | 172 | 51 | 746 |
| Pre-tax Income | -17,606 | -9,834 | -7,263 | -6,220 | -5,537 |
| Net Income Continuous | -17,606 | -9,834 | -7,263 | -6,220 | -5,537 |
| Net Income | $-17,606 | $-9,834 | $-7,263 | $-6,220 | $-5,537 |
| EPS Basic Total Ops | -0.63 | -0.39 | -0.37 | -0.32 | -0.32 |
| EPS Basic Continuous Ops | -0.63 | -0.40 | -0.37 | -0.32 | -0.32 |
| EPS Diluted Total Ops | -0.63 | -0.39 | -0.37 | -0.32 | -0.32 |
| EPS Diluted Continuous Ops | -0.63 | -0.40 | -0.37 | -0.32 | -0.32 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.39 | -0.37 | -0.32 | -0.32 |
| EBITDA(a) | $-18,012 | $-9,706 | $-7,435 | $-6,272 | $-6,283 |